丙种球蛋白过敏的再发川崎病患儿1例(2)
[2] Matsuoka S，Tatara K，Nakagawa R，et al. Tendency toward atopy in Kawasaki disease[J]. Eur J Pediatr，1997，156(1)：30-32.
[3] Liew WK，Lim CW，Tan TH，et al. The effect of Kawasaki disease on childhood allergies ——a sibling control study[J]. Pediatr Allergy Immunol，2011，22(5)：488-493.
[4] Furukawa S，Matsubara T，Motohashi T，et al. Increased expression of Fc epsilon R2/CD23 on peripheral blood B lymphocytes and serum IgE levels in Kawasaki disease[J]. Int Arch Allergy Appl Immunol，1991，95(1)：7-12.
[5] Kabesch M，Tzotcheva I，Carr D，et al. A complete screening of the IL4 gene： novel polymorphisms and their association with asthma and IgE in childhood[J]. J Allergy Clin Immunol，2003，112(5)：893-898.
[6] Burns JC，Shimizu C，Shike H，et al. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease[J]. Genes Immun，2005，6(5)：438-444.
[7] Newburger JW，Sleeper LA，Mc Crindle BW，et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease[J]. N Engl J MED， 2007，356(7)：663-675.
[8] El-Shanawany T，Sewell WA，Misbah SA，et al. Current clinical uses of intravenous immunoglobulin[J]. Clin Med，2006，6(4)：356-359.
(收稿日期：2012-01-17), 百拇医药(宋俊峰 黄先玫)
[3] Liew WK，Lim CW，Tan TH，et al. The effect of Kawasaki disease on childhood allergies ——a sibling control study[J]. Pediatr Allergy Immunol，2011，22(5)：488-493.
[4] Furukawa S，Matsubara T，Motohashi T，et al. Increased expression of Fc epsilon R2/CD23 on peripheral blood B lymphocytes and serum IgE levels in Kawasaki disease[J]. Int Arch Allergy Appl Immunol，1991，95(1)：7-12.
[5] Kabesch M，Tzotcheva I，Carr D，et al. A complete screening of the IL4 gene： novel polymorphisms and their association with asthma and IgE in childhood[J]. J Allergy Clin Immunol，2003，112(5)：893-898.
[6] Burns JC，Shimizu C，Shike H，et al. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease[J]. Genes Immun，2005，6(5)：438-444.
[7] Newburger JW，Sleeper LA，Mc Crindle BW，et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease[J]. N Engl J MED， 2007，356(7)：663-675.
[8] El-Shanawany T，Sewell WA，Misbah SA，et al. Current clinical uses of intravenous immunoglobulin[J]. Clin Med，2006，6(4)：356-359.
(收稿日期：2012-01-17), 百拇医药(宋俊峰 黄先玫)